NewsWorld
PredictionsDigestsScorecardTimelinesArticles
NewsWorld
HomePredictionsDigestsScorecardTimelinesArticlesWorldTechnologyPoliticsBusiness
AI-powered predictive news aggregation© 2026 NewsWorld. All rights reserved.
Trending
FebruaryChinaSignificantMilitaryTimelineDigestFaceDiplomaticFederalTurkeyFridayTrumpDrugGovernanceTensionsCompanyStateIranParticularlyEscalatingCaliforniaTargetingNuclearDespite
FebruaryChinaSignificantMilitaryTimelineDigestFaceDiplomaticFederalTurkeyFridayTrumpDrugGovernanceTensionsCompanyStateIranParticularlyEscalatingCaliforniaTargetingNuclearDespite
All Articles
Best Month in a Year for Treasuries
Bloomberg
Clustered Story
Published about 6 hours ago

Best Month in a Year for Treasuries

Bloomberg · Feb 27, 2026 · Collected from RSS

Summary

Kelsey Berro, fixed income portfolio manager at JPMorgan Asset Management, and Subadra Rajappa, head of research at Société Générale Americas, join Matt Miller and Emily Graffeo on "Bloomberg Real Yield." US bonds are wrapping up their best monthly performance in a year against a backdrop of rising global risks, with resurgent demand serving as proof that investors still see Treasuries as the premier haven in turbulent times. (Source: Bloomberg)

Share this story
Read Original at Bloomberg

Related Articles

Bloombergabout 15 hours ago
Treasuries Are Still the Place to Be in a Turbulent World

US government debt posts its biggest monthly gain in a year amid AI angst.

Bloombergabout 16 hours ago
Treasuries Regain Edge as Safety Play With Best Month in Year

US bonds are wrapping up their best monthly performance in a year against a backdrop of rising global risks, with resurgent demand serving as proof that investors still see Treasuries as the premier haven in turbulent times.

Bloombergabout 2 hours ago
Stocks Slide as Credit Stress, War and AI Fears Weigh | The Close 2/27/2026

Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are Robinhood Markets’ Stephanie Guild, Generate:Biomedicines’ Mike Nally, S&P Global’s Simon Gallagher, Inflation Insights’ Omair Sharif, Lightshed Partners’ Rich Greenfield, Fidelity’s Jurrien Timmer, Institute for Advance Study’s Alondra Nelson, Hornets Sports and Entertainment’s Shelly Cayette-Weston, Raising Cane’s Aj Kumaran, and Carnegie Endowment for International Peace Senior Fellow Aaron David Miller. (Source: Bloomberg)

Bloombergabout 2 hours ago
Ex-Moelis Banker to Plead Guilty in Global Insider Trading Case

A former Moelis & Co. investment banker plans to return to the US from France to plead guilty to tipping off members of a global insider-trading ring.

Bloombergabout 2 hours ago
President Trump’s Economy: Boom, Bust, or Business as Usual?

President Trump says inflation is plunging, incomes are rising, and the economy is “roaring.” Former Obama economic adviser Jason Furman offers a reality check. Growth has been steady and unemployment stable, but tariffs are adding costs, policy uncertainty remains high, and the AI boom may not yet justify massive investment. With the Supreme Court striking down key tariffs and refund battles looming, the bigger question is whether today’s stability masks deeper long-term risks. (Source: Bloomberg)

Bloombergabout 2 hours ago
The Key to a Healthy Woman's Heart

February is American Heart Month, known as a critical time for bringing increased attention to cardiovascular health and the prevention of heart disease, which is the leading cause of death in the US. Women are particularly vulnerable to cardiac health threats spanning biological, clinical and healthcare system factors that contribute to underdiagnosis, delayed treatment, and worse outcomes compared to men. Dr. Joy Gelbman, Associate Professor of Medicine at Weill Cornell Medicine as well as a board-certified cardiologist, is well-versed in the unique challenges facing women when it comes to their cardiac health. She breaks down specific sex-specific risk factors, differing disease presentation and pathophysiology, as well as the experience disparities in treatments and outcomes. Dr. Gelbman speaks with Carol Massar and Tim Stenovec on Bloomberg Businessweek Daily. (Source: Bloomberg)